Martin Oft
Vice President
Pre-Clinical and Clinical Development
ARMO Biosciences
Japan
Biography
Martin Oft, MD has over 19 years of experience in Biotechnology and Pharmaceutical Research and Development. Most recently he co-founded ARMO to develop immune therapies for the treatment of cancer and other diseases. Prior to ARMO, Martin held positions at DNAX Research Inc. of Schering Plough in Palo Alto, now Merck Research Labs. There, he led multiple development teams to progress immune therapies for the treatment of cancer and led the efforts for the discovery and development of PEGylated IL-10. Previously, Martin served at Onyx Pharmaceuticals, the UCSF Cancer Center, and Boehringer Ingelheim. Martin holds an MD degree and medical license from the University of Erlangen, Germany. He performed his postdoctoral research at the Institute of Molecular Pathology in Vienna, Austria. Martin published numerous scientific articles and reviews on cancer progression and the immune response to cancer and he is an inventor on a number of cancer therapy patents.
Research Interest
Oncology
